One biologic, adalimumab, is currently approved to treat hidradenitis suppurativa. Adalimumab works by targeting a specific inflammation pathway involved in the condition. Hidradenitis suppurativa (HS ...
Biologic drugs for asthma may be initiated or continued while conceiving or during pregnancy or breastfeeding following appropriate risk-benefit discussions and shared decision-making, a consensus ...
The US Food and Drug Administration (FDA) has approved more than 23,000 prescription drugs, with many more in development. Increasingly, therapeutic manufacturers are discovering that the key to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback